Cellis logo

Cellis jobs and careers

Switzerland

About Cellis

Cellis is a biotechnology company developing macrophage-based cancer therapy for the treatment of solid tumors. We specialize in innovative cell-based oncology approaches, with a focus on overcoming resistance in difficult-to-treat cancers. Our proprietary platform, Macrophage Drug Conjugate (MDC), is based on the TRAIN mechanism, enabling targeted delivery of active compounds directly into the cytoplasm of cancer cells. This results in tumor cell death while simultaneously reshaping the tumor microenvironment to enhance anti-cancer immune responses. Cellis is advancing its pipeline toward first-in-human clinical trials, while building a strong intellectual property portfolio supported by PCT patent applications and ongoing filings.

Founded
2016
Employees
11 to 50
Headquarters
Switzerland

Leadership

The top of Cellis's org chart, with how many people report into each leader.

RAPhoto of Robert Aleksandrowicz

Robert Aleksandrowicz

Chief Executive Officer